Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
FibroBiologics, Inc. - Common Stock
(NQ:
FBLG
)
1.580
-0.050 (-3.07%)
Streaming Delayed Price
Updated: 11:16 AM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about FibroBiologics, Inc. - Common Stock
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
August 20, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics Files 2024 Second Quarter Report
August 07, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
July 15, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
June 25, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics Set to Join Russell 2000® Index
June 13, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
June 06, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics Announces 2024 Annual Meeting of Stockholders
May 15, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics Files 2024 First Quarter Report
May 14, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics to Present at the BIO International Convention 2024
May 07, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
April 25, 2024
Next-generation cell therapies to target chronic diseases
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
April 04, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
March 28, 2024
From
Fibrobiologics, Inc.
Via
GlobeNewswire
FibroBiologics (NASDAQ: FBLG) Shares Jump 88% After Announcing Preclinical Data During Presentation at 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
February 13, 2024
FibroBiologics (NASDAQ: FBLG) shares caught a notable bid during trading on Tuesday, February 13, 2024. The clinical-stage biotech company saw
Via
Spotlight Growth
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.